INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 414m ago
HOUSE PTR14m ago
SEC 13F14m ago
ROBINHOOD CHAIN14m ago
Corporate insider
SS

Sayad Pierre Sargis

Chief Medical OfficerCIK 0002043395

EDGAR filingsOpen in network
Disclosed transactions12
Buys / sells0 / 1
Max Insider Score36
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
5
SS
Sayad Pierre SargisChief Medical Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
168 sh
Oct 31, 2026Nov 2, 2026
traded Oct 31, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    FENNEC PHARMACEUTICALS INC.Chief Medical Officer · Apr 2, 2026
13
SS
Sayad Pierre SargisChief Medical Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A
$21K
3,846 sh
Oct 12, 2026
Oct 13, 2026
traded Oct 12, 2026
+1d
SEC FORM 4

Evidence

5
SS
Sayad Pierre SargisChief Medical Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
168 sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC FORM 4

Evidence

36
SS
Sayad Pierre SargisChief Medical Officer
FENCFENNEC PHARMACEUTICALS INC.
Open-market sale
SELL$146K
12.0K sh
Aug 31, 2026Aug 31, 2026
traded Aug 31, 2026
+0dSEC FORM 4

Evidence

9
SS
Sayad Pierre SargisChief Medical Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
168 sh
Aug 31, 2026Aug 31, 2026
traded Aug 31, 2026
+0dSEC FORM 4

Evidence

9
SS
Sayad Pierre SargisChief Medical Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
168 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC FORM 4

Evidence

9
SS
Sayad Pierre SargisChief Medical Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
168 sh
May 31, 2026Jun 1, 2026
traded May 31, 2026
+1dSEC FORM 4

Evidence

9
SS
Sayad Pierre SargisChief Medical Officer
FENCFENNEC PHARMACEUTICALS INC.
Option exercise
M—
168 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC FORM 4

Evidence

9
SS
Sayad Pierre SargisChief Medical Officer
FENCFENNEC PHARMACEUTICALS INC.
Option exercise
M—
171 sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC FORM 4

Evidence

19
SS
Sayad Pierre SargisChief Medical Officer
FENCFENNEC PHARMACEUTICALS INC.
Option exercise
M—
2,052 sh
Mar 28, 2026Apr 2, 2026
traded Mar 28, 2026
+5dSEC FORM 4

Evidence

27
SS
Sayad Pierre SargisChief Medical Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A$692K
120.0K sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC FORM 4

Evidence

9
SS
Sayad Pierre SargisChief Medical Officer
FENCFENNEC PHARMACEUTICALS INC.
Option exercise
M—
18.5K sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC FORM 4

Evidence